Amyloid-beta 1-40 is associated with alterations in NG2+ pericyte population ex vivo and in vitro

Research output: Contribution to journalArticle

Abstract

The population of brain pericytes, a cell type important for vessel stability and blood brain barrier function, has recently been shown altered in patients with Alzheimer's disease (AD). The underlying reason for this alteration is not fully understood, but progressive accumulation of the AD characteristic peptide amyloid-beta (Aβ) has been suggested as a potential culprit. In the current study, we show reduced number of hippocampal NG2+ pericytes and an association between NG2+ pericyte numbers and Aβ1-40 levels in AD patients. We further demonstrate, using in vitro studies, an aggregation-dependent impact of Aβ1-40 on human NG2+ pericytes. Fibril-EP Aβ1-40 exposure reduced pericyte viability and proliferation and increased caspase 3/7 activity. Monomer Aβ1-40 had quite the opposite effect: increased pericyte viability and proliferation and reduced caspase 3/7 activity. Oligomer-EP Aβ1-40 had no impact on either of the cellular events. Our findings add to the growing number of studies suggesting a significant impact on pericytes in the brains of AD patients and suggest different aggregation forms of Aβ1-40 as potential key regulators of the brain pericyte population size.

Details

Authors
Organisations
External organisations
  • Umeå University
  • Stockholm University
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Neurosciences
Original languageEnglish
Article numbere12728
JournalAging Cell
Volume17
Issue number3
Early online date2018 Feb 17
Publication statusPublished - 2018
Publication categoryResearch
Peer-reviewedYes

Related research output

Nina Schultz, 2018, Lund: Lund University: Faculty of Medicine. 106 p.

Research output: ThesisDoctoral Thesis (compilation)

View all (1)